Peppermint oil

Phase 1Small molecule

TThe University of Texas Health Science Center at San Antonio

Peppermint oil is one of 78 small molecule programs targeting Interstitial Cystitis. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Interstitial CystitisActive, not recruiting

Abdominal PainActive, not recruiting

Interstitial CystitisPhase 1/Phase 2

Active, not recruiting

Abdominal PainPhase 1

Active, not recruiting

Competition

Competitive Landscape

72 competitors in Interstitial Cystitis

#DrugCompanyPhaseTrials

Neurontin

VViatris Specialty LLC

Xolair

1 3

Myrbetriq

Astellas

Phase 3

1 4

Cimzia

UCB

Phase 3

1 5

Intron a

Sanofi

Phase 3

1 6

Low-Dose Naltrexone

SStanford University

Approved

1 7

Humira

CCelltrion

Phase 3

1 8

Sodium Hyaluronate

Sanofi

Phase 3

1 9

Quietus

Merck & Co.

Phase 2

1 10

Ajovy

Teva

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Acute1 trial

Use of Aromatherapy in Conjunction With Physical/Occupational Therapy in an Acute Care Setting

Enrolling by invitation·TThe University of Texas Health Science Center at San Antonio·Phase 1·NCT05282706·200 enrolled

Tics1 trial

Peppermint Oil Pharmacokinetics/Dynamics

Withdrawn·—·Phase 1·NCT04497870

Interstitial Cystitis1 trial

Peppermint Oil for the Treatment of Interstitial Cystitis / Bladder Pain Syndrome

Recruiting·UUniversity of Louisville·Phase 1/2·NCT04845217·100 enrolled

Colonoscopy1 trial

L-Menthol Injection as a Novel Technique During Colonoscopy

Terminated·UUniversity Hospitals Cleveland Medical Center·Phase 3·NCT02588248·82 enrolled

Abdominal pain1 trial

Peppermint Oil Pharmacokinetics/Dynamics and Novel Biological Signatures in Children With Functional Abdominal Pain

Completed·—·Phase 1·NCT03295747·30 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Peppermint oil. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Peppermint oil compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Peppermint oil. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — The University of Texas Health Science Center at San Antonio company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: TThe University of Texas Health Science Center at San Antonio

Peppermint oil

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Acute1 trial

Tics1 trial

Interstitial Cystitis1 trial

Colonoscopy1 trial

Abdominal pain1 trial

References

Drug Info

Quick Facts

Related News